Eco Animal Health Group deliver strong resilient performance (Interview)

ECO Animal Health Group plc (LON:EAH) CEO Marc Loomes joins DirectorsTalk to discuss results for the year ended 31st March 2021. Marc talks us through the highlights, explains the key markets and how they performed, how the pandemic impacted the group, what has driven a 44% increase in demand for Aivlosin and how Marc would describe the outlook for the company.

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
ECO Animal Health Group plc

More articles like this

ECO Animal Health Group plc

Eco Animal Health Group AGM to be held on 16 September 2021

ECO Animal Health Group plc (LON:EAH) has announced the publication of the following documents on the Company’s website: www.ecoanimalhealthgroupplc.com/investor-relations.aspx. ·    Annual Report and Accounts for the year ended 31 March 2021 ·    Notice of the Annual General Meeting (“AGM”) to be

ECO Animal Health Group plc

ECO Animal Health Group sales up 46% at £105.6m

ECO Animal Health Group plc (LON:EAH) has announced its results for the year ended 31 March 2021. HIGHLIGHTS Financials · Sales up 46% at £105.6m (2020: £72.1m) · Gross margin increased to 51% (2020: 46%) · Profit before tax increased significantly

ECO Animal Health Group plc

Eco Animal Health resilient performance with sales 7% higher at £72.1m

ECO Animal Health Group plc (LON:EAH) has reported its results for the year ended 31 March 2020. HIGHLIGHTS Financials ·      Sales 7% higher at £72.1m (2019 restated: £67.3m) ·      Gross margin consistent to within 1% (2020 46%, 2019 47%) ·      Increased

ECO Animal Health Group plc

ECO Animal Health receive marketing authorisation for swine vaccine

ECO Animal Health Group plc (LON:EAH) has announced that it has received a marketing authorisation from Brazil’s Ministry of Agriculture, Livestock and Food Supply for Circo/MycoGard®, a vaccine for swine. Circo/MycoGard® is used for the vaccination of healthy piglets